MK

Manish Kesherwani

Active Director Managing Director DIN 11883691
DIN 11883691 First appointment Aug 2026
Unlock full profile Investments Β· shareholding Β· contact details
Current companies 1 active board seats
Total affiliations 1 Since Aug 2026
Shareholding value β€’β€’β€’β€’ Premium profile

About Manish Kesherwani

Manish Kesherwani is a Managing Director at Ensolva Bioai Private Limited (since 2026).

DIN 11883691
Primary Designation Managing Director
First Appointment 11 Aug 2026

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Ensolva Bioai Private Limited U72100UP2026PTC251264
Managing Director11 Aug 20262026Active

Board colleagues of Manish Kesherwani

NameDINCompanyDesignation
Niraj Kesherwani11883690Ensolva Bioai Private LimitedWhole-Time Director

Directorship timeline

Open interactive timeline →
Ensolva Bioai Private Limited
Premium access

Shareholding and investment profile for Manish Kesherwani

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Manish Kesherwani

Manish Kesherwani currently holds 1 directorship: Ensolva Bioai Private Limited (Managing Director, since 11 Aug 2026).

Manish Kesherwani was first appointed on 11 Aug 2026 as Managing Director at Ensolva Bioai Private Limited.

The current boards of Manish Kesherwani's companies include Niraj Kesherwani (Ensolva Bioai Private Limited).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available